Do protein supplementation increase health-related QoL in advanced chronic kidney disease? Check out the recap thread made by NephJC intern Clemens Weber
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
This week, we will discuss the VALIANT study, pegcetacoplan in C3G and IC MPGN.
2025 was rich in successful stories. Here are the top 10 that impressed our audience.
This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.
Do protein supplementation increase health-related QoL in advanced chronic kidney disease? Check out the recap thread made by NephJC intern Clemens Weber
1/10 Last #NephJC we tried to answer the question whether protein supplementation increases health-related QoL 🥩💊 #TenPostNephJC
— Nephrology Journal Club (@NephJC) November 24, 2025
Read the article 👇https://t.co/tFWDcvIc3u pic.twitter.com/FtOGwSNR88